MASP-2 concentrations underwent highly significant treatment-associated changes in both groups of patients, independently of complications (Figure 3C ).
← all excerpts
The Role of Complement Activating Collectins and Associated Serine Proteases in Patients With Hematological Malignancies, Receiving High-Dose Chemotherapy, and Autologous Hematopoietic Stem Cell Transplantations (Auto-HSCT).
1
—
—